cik0-20230203
0001584509false00015845092023-02-032023-02-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K
____________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
February 3, 2023
Date of Report (Date of earliest event reported)
____________________________
Aramark
(Exact name of Registrant as Specified in its Charter)
____________________________
Delaware001-3622320-8236097
(State or other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2400 Market Street19103
Philadelphia,Pennsylvania
   (Address of Principal Executive Offices)(Zip Code)
(215)
238-3000
(Registrant's Telephone Number, Including Area Code)
N/A
(Former name or former address, if changed since last report.)
__________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading Symbol(s)Name of Each Exchange on which Registered
Common Stock, par value $0.01 per shareARMKNew York Stock Exchange

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02.     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 3, 2023, Aramark (the “Company”) held its 2023 Annual Meeting of Shareholders (the “2023 Annual Meeting”) at which the Company’s shareholders approved the Company’s 2023 Stock Incentive Plan (the “Plan”).

As provided in the Plan, 8,500,000 shares of the Company’s common stock, par value $0.01 per share, are available for issuance thereunder, subject to adjustments as described in the Plan. The Plan was previously approved by the Company's Board of Directors (the “Board”), subject to shareholder approval. The Plan became effective as of the date of such shareholder approval. The material features of the Plan are described in the Company’s definitive proxy statement for the 2023 Annual Meeting filed on December 23, 2022 (the “Proxy Statement”), under the heading "Proposal No 4 - Vote to Approve Aramark 2023 Stock Incentive Plan," which is incorporated herein by reference. The above and incorporated description of the Plan is qualified in its entirety by reference to the Plan, which is included at Appendix A to the Company's Proxy Statement, and incorporated herein by reference as Exhibit 10.1 to this Form 8-K.

Item 5.07.     Submission of Matters to a Vote of Security Holders.
The Company held its 2023 Annual Meeting on February 3, 2023. At the meeting shareholders voted on the matters disclosed in the Company’s Proxy Statement filed on December 23, 2022. Set forth below are the final voting results with respect to each matter voted upon by the Company’s shareholders:
1.Election of each of the following 11 director nominees to the Company’s Board to serve until the Company’s 2024 Annual Meeting or until his or her respective successor has been duly elected and qualified:


Nominees for DirectorForAgainstAbstentionsBroker Non-Votes
Susan M. Cameron194,682,682 3,398,372 180,960 14,011,565
Greg Creed197,410,378 669,605 182,031 14,011,565
Bridgette P. Heller195,815,822 2,263,710 182,482 14,011,565
Paul C. Hilal196,080,051 1,999,112 182,851 14,011,565
Kenneth M. Keverian197,640,777 437,989 183,248 14,011,565
Karen M. King197,654,391 424,379 183,244 14,011,565
Patricia E. Lopez197,073,660 1,008,483 179,871 14,011,565
Stephen I. Sadove189,771,386 8,308,408 182,220 14,011,565
Kevin G. Wills197,814,659 384,652 62,703 14,011,565
Arthur B. Winkleblack196,332,800 1,747,161 182,053 14,011,565
John J. Zillmer194,863,046 3,345,656 53,312 14,011,565


2.Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 29, 2023:


ForAgainstAbstentionsBroker Non-Votes
211,041,626 1,060,426 171,527 0





3.Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement for the 2023 Annual Meeting of Shareholders filed on December 23, 2022:


ForAgainstAbstentionsBroker Non-Votes
190,014,227 8,028,958 218,829 14,011,565


4.Approval of the Aramark 2023 Stock Incentive Plan:


ForAgainstAbstentionsBroker Non-Votes
184,359,080 13,800,589 102,345 14,011,565


Item 9.01.     Financial Statements and Exhibits 
 (d)Exhibits

Exhibit
No.
 Description
 
104Cover Page Interactive Date File (embedded within the Inline XRBL document)




SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.




Aramark
Date:February 3, 2023By:/s/ LAUREN A. HARRINGTON
Name:LAUREN A. HARRINGTON
Title:Senior Vice President and
General Counsel